SCHEMBL10303195

SCHEMBL10303195

CCCC(O)c1ccc(OCc2ccc(-c3ccc(O)c(F)c3F)cc2)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 2/20 0.39
▸ MRGPRX4 Q96LA9 1/20 0.35
▸ S1PR5 Q9H228 1/20 0.34
▸ ERN1 O75460 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ CYP3A4 P08684 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ GCGR P47871 1/20 0.33
▸ FAAH O00519 1/20 0.33
▸ PDE4A P27815 2/20 0.33
▸ PDE4B Q07343 2/20 0.33
▸ PDE4C Q08493 2/20 0.33
▸ PDE4D Q08499 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ APP P05067 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ ALOX5 P09917 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10303179 0.91 FFAR1 (0.40) FFAR1MRGPRX4S1PR5ERN1FFAR4
SCHEMBL12822925 0.90 FFAR4 (0.33) FFAR1MRGPRX4FFAR4CYP3A4TSHR
SCHEMBL12823854 0.90 FFAR4 (0.33) FFAR1MRGPRX4FFAR4CYP3A4TSHR
SCHEMBL12823598 0.89 FFAR1 (0.36) FFAR1MRGPRX4S1PR5ERN1FFAR4
SCHEMBL12821319 0.86 CYP17A1 (0.39) FFAR1ERN1FFAR4CYP3A4GCGR
SCHEMBL13586388 0.84 FAAH (0.42) FFAR1S1PR5ERN1FFAR4FAAH
SCHEMBL10303187 0.84 FFAR1 (0.35) FFAR1MRGPRX4S1PR5ERN1FFAR4
SCHEMBL10303094 0.84 FFAR1 (0.35) FFAR1MRGPRX4S1PR5ERN1FFAR4
SCHEMBL13654000 0.84 PDE4D (0.36) FFAR1MRGPRX4S1PR5FFAR4PDE4A
SCHEMBL12823210 0.83 ABCB1 (0.38) FFAR1FFAR4CYP3A4FAAHAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8216489-B2 Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-07-10 — — US disclosed
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2011-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE LEF1, LAS1L, L3MBTL3 FFAR1 681/4885MRGPRX4 4652/4885S1PR5 2691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback